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reduction in 4 inpatient days per case. Patient and caregiver satis- 
faction has been high and the rate of readmission has remained 
constant. 
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IMPLEMENTATION OF A PROCESS INITIATIVE ON THE BLOOD AND 
MARROW TRANSPLANT UNIT THAT HAS INCREASED OVERALL FAMI- 
LY SATISFACTION WITH QUALITY OF CARE 
Cuthrell, P.; Beutel, K.; l~dser, P. Blood m~d Marrozv Transplant Unit, 
Ci~zcinnati ChildrenS"Ho~pital 3/ledical Center, Cincim~ati, OH. 
The Blood and Marrow Transplant (BMT) Unit has imple- 
mented a hospital-wide patient care delivery methodology which 
has resulted in increased overall f:amily satisfaction. This model, 
known as Patient Care and Access Process Initiative (PCAPI) 
focuses on unit ing the patient care team including the 
patienfffamily. The central concept is to facilitate the customer 
service aspect of care delivery. Employees are recognized for their 
efforts to treat their customers with courtesy, attentiveness, 
respect, confidentiality and in a safe environment. Through 
defined roles, patients are oriented to their environment and to 
the resources of the care delivery systems. The PCAPI team 
develops collaboration on the plan of care documentation, educa- 
tion and discharge process. PCAPI provides a forum to ensure 
that the patient and family are as involved in the plan of care as 
they choose to be. Methods of presenting rounds are tailored to 
the unique needs and circumstances of the family. BMT patient- 
centered rounds ensure that resident physicians and nurses are 
receiving clinical education and role modeling in both medical and 
family-centered concepts. Caregivers communicate their child's 
needs through verbal interactions on rounds and written docu 
mentation in the medical record. Over the past 10 months, satis- 
faction scores were evaluated. Results from family satisfaction sur- 
veys completed prior to and after the init iation of PCAPI ,  
revealed scores of 7.1 (pre) and 9 (post). The scores ranged from 0 
(lowest) to 10 (highest). The data obtained from an n=29 pre- 
PCAPI surveys and an n=28 post-PCAPI surveys revealed an 
overall increase in satisfaction in quality of care delivered to the 
patients. For the future of family centered care here at Cincinnati 
Children's BMT Unit it is necessary to continue to build the team 
approach to care, connecting with the patient/family every step of 
the way. 
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BMT-EZ: INNOVATIVE COMMUNICATION VEHICLE IN TRACKING 
BONE MARROW TRANSPLANT PATIENTS 
Cruz, E.; Adornetto, D.L.; Calam~sa, J.; Harris, S.; Hontiveros, R.; 
Sta'ly, S. BMT Center, UT MD Anderson, Houston, TX. 
At one of the largest blood and *narrow transplant centers in the 
world, the BMT patient ravels through a complex process from 
evaluation by the BMT physician, through pre-evaluation testing, 
financial clearance, admission work-up and transplant. It was 
determined through consensus of the team and by observation of 
interactions between team members thatpatient follow-up was 
inconsistent amongst he multidisciplinary care team. For ma W 
years, a patient racking list has been utilized as a tool to follow 
the progress of patients through transplant. It recently has evolved 
into the main communication i strument utilized by the clinic 
coordinators, patient access coordinators/specialist, matched- 
unrelated onor coordinators, social workers, research nurses, 
research data coordinator, administrative director, nurse manager, 
business center manager and supervisor.' The list is identified as 
the BMT-EZ, a vital communication vehicle capable of being 
updated from multiple multidisciplinary workstations and easily 
accessible by the team. This tracking includes transplant patients 
listed by doctor and also includes diagnosis, consult date, trans- 
plant type, protocol assignment, and financial and clinical com- 
ments. The financial column is updated by the business center 
patient access nurse coordinators to communicate approvals, 
denials, and other financial interventions. The clinical notes are 
updated by the clinic nurse coordinators as the patients clinical 
status changes. The multidisciplinary team attends aweekly track- 
ing meeting facilitated by the BMT clinic nurse coordinators. The 
clinic coordinator reviews the BMT-EZ tracking list and provides 
new clinical updates to the team. The multidisciplinary team is 
encouraged to offer additional information ot noted on the 
tracking list on any patients during this meeting. This regular 
meeting, coupled with the use of the tracking list, has minimized 
the possibility of a patient falling thru the cracks or being lost in 
our complex system. Currently, patients have a smoother transi- 
tion from consultation to transplant admission thus creating a 
high level of patient satisfaction and role clarification amongst the 
nmltidisciplinary team. 
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CARE OF THE AUTOLOGOUS BLOOD AND MARROW TRANSPLANT 
PATIENT IN A FAST PACED CLINIC WITH A MULTIDISCIPLINARY 
TEAM APPROACH 
Baughmm~, E.E.; Ha~wis, C.; Tho'rnton, T.; l~ash, V.; Rhodes, B.; Ne~- 
mann, ft. Blood and ]Vlarrozz, Transpla~tatio~ Center, UT 3I.D. 
Amlerson CaTzcer Center, Ho'tlston, T2C 
The nursing goal for the Blood and Marrow Transplant (BMT) 
Fast Track Clinic is to provide point-of-service are to meet the 
needs of autologous patients in an efficient manner that fosters 
quality of care. The Fast Track multidisciplinal T team consists of: 
an advanced practice nurse, clinic nurse, clinical pharmacist, phle- 
botomist, and a scheduling coordinator. This team collaborates to 
address the various symptoms presented by this population such as 
nausea, diarrhea, pain and fatigue. Fast Track is located within the 
BMT Clinic with several exam rooms designated for use. Patients 
have labs drawn in the morning by the phlebotomist who facili- 
tates timely return of results. The clinic nurse then performs an 
initial patient assessment. Once lab results are available, the team 
further assesses the patient. Treatments  uch as electrolyte 
replacements and intravenous fluids are administered by ambula- 
tory IV pumps. Infusions greater than one hour and blood prod- 
uct transfusions are transitioned to ambulatory clinics capable of 
longer-term infusions. Post-mobilization patients are transitioned 
to the apheresis clinic once their CD34+ counts are adequate. 
BMT physicians evaluate patients once a week until their absolute 
neutrophil count is stable and they are able to transition off of 
intravenous fluids. At that time, the patient is "graduated" from 
Fast Track, down the hallway, back to their physician's regular 
clinic. Monthly patient satisfaction surveys and daily comment 
cards are used to evaluate the patient perception of care and the 
nursing goal of Fast Track. Data such as patient volume, room 
usage, and types of treaunents administered are documented on a 
daily spreadsheet. This data is reviewed by the Fast Track multi- 
disciplinary team on a monthly basis to trend and implement qual- 
ity improvements a needed. 
28O 
MISSED APPOINTMENTS: WHAT ARE THEY AND WHY DO THEY 
HAPPEN? 
Hughes, S.E.; Stary, S.ff.; Adornetto, D.L. BMT Center, UT 3lID 
Anderson, Houston, T~ 
Blood and Marrow Transplant patients require care, time, and 
follow-up. At one of the largest ransplant centers in the world, 
performing over 550 transplants per year, scheduling patient 
appointments and assuring these appointments are kept presents a 
challenge. Monthly activity reports demonstrate an average of 200 
missed appointments per month including new patients, consults, 
and follow~ups. In an effort to address this issue, it was deter- 
mined that the missed appointment policy and procedure needed 
to be updated and the utilization of the missed appointment log 
needed to be reviewed with staff. There were also many staff 
members that were unaware of the current policy and questioned 
who was responsible for contacting patients who had missed 
his/her appointment. I  was unsure why appointments were being 
missed; therefore, presenting concerns regarding patient follow 
thru and clinic flow. This resulted in a performance improvement 
project to address ways to improve this process and to assure 
patients are being seen appropriately and timely. As a result, re- 
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education of staff regarding the policy and procedure and the 
newly revised missed appointment log has been instituted. With 
the revision of the missed appointment log, the nurse can track 
the type of appointment missed, the physician, reasons for the 
missed appointments, and impending follow up. As for new 
patients or consults, a change was implemented requiring the 
scheduler to contact the patient confirming the appointment date 
and time. This is a project hat will and has led ns to look at ways 
to improve clinic flow to assure that patients are receiving the best 
quality of care before and after t ansplant. 
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WHEN DYSPNEA BECOMES AN ONCOLOGIC EMERGENCY FOR 
BLOOD AND MARROW TRANSPLANTATION (BMT) PATIENTS: DIF- 
FUSE ALVEOLAR HEMORRHAGE 
Hi~cls, L.; Brandert, M.; Neuman~, J. University of Texas MD 
Amterson Cmzcer CeJ~te~, HoHsto~, TX. 
Diffuse alveolar hemorrhage (DAH) in any patient can Iead to a 
life-threatening situation, but in general the risk of occurrence is
low with reported incidents varied from 2-20%. Prompt reatment 
is essential. When untreated mortality hasbeen reported in excess 
of 75%. In the BMT patient the risk factors are increased for sev- 
eral reasons aside from low platelets during the period of pancy- 
topenia. Other risk factors include: chemotherapy, total body irra 
diation (TBI), infection, and old age. Because of these risk factors, 
the clinical nurse caring for the BMT patient during the period of 
engraftment is responsible for being hyper-vigilant and acting 
immediately upon subtle respiratory changes. The signs and 
symptoms of DAH include: dyspnea; hemoptysis; hypoxia demon- 
strated by decrease in 02 saturations; change in respiratory status- 
cough, tachypnea, use of accessory muscles, decrease in breath 
sounds; anxiety; confiision; restlessness; and heart palpitations. At 
our comprehensive cancer center where over 500 BMT patients 
are treated and cared for each year, the unit-based clinical practice 
council has developed a DAH standard of care that identifies prac- 
tice guidelines. These include general information about DAH 
and principles of treatment; our policy containing uidelines and 
responsibilities of the nurse to inform the medical team; and nurs 
ing interventions. On our unit these interventions may include: 
administration of Solu-Medrol, Lasix, DDAVP, Amicar, and a 
cough suppressant; initiation of O2 to keep saturations above 
95%; and infusing platelets. Additional diagnostic assessments 
may include ABGs, portable chest x-ray, and bronchoscopy. Pro- 
tocols involving the use of activated Factor VII for DAH are also 
being examined to improve hemostasis. Recognition of acute 
bleeding, including DAH, is a competency that is tested yearly on 
our unit. DAH case reviews are discussed at stafffclinical practice 
meetings. A case review, including immediate nursing interven- 
tions, and outcomes data of DAH at our center will be presented. 
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THROMBOTIC THROMBOCYTOPENIA PURPURA AND HEMOLYTIC 
UREMIC SYNDROME IN BONE MARROW TRANSPLANT 
Shelb~lrl~e, N.F. Nurshlg Department, NatioJml h~stitlltes of H ahh, 
Silver Sp'rilzg, kiD. 
Thrombotic thrombocytopenia purpura (TTP) and hemolytic 
uremic syndrome (HUS) are multisystem, microvascular, platelet 
clumping disorders, associated with cancer, chemotherapy, 
immunosuppressive drugs, and bone marrow transplant (BMT). 
TTP and HUS, although rare, have a high mortality rate even 
with early recognition and intervention. Endothelial cell damage, 
secondary to irradiation, chemotherapy, and immunosuppressive 
drugs, initiates a cellular cascade that places BMT patients at risk 
for developing TTP  and HUS. The clinical manifestations of
these syndromes include hemolytic anemia, thrombocytopenia, 
renal failure, fever, and neurological changes. In BMT patients, 
making an early diagnosis of these syndromes may be difficult 
with thrombocytopenia and anemia lready present. The standard 
treatment for BMT related T I 'P  and HUS are plasma exchange 
and change of innnunosuppressive agents, as cyclosporine and 
tacrolimns (FKS06) have been implicated in causing these syn- 
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dromes. Von YVillebrand factor (vWF) is a normally occurring 
factor in the blood that assists in platelet aggregation, but in TFP 
and HUS, there is an excess number that are abnormal in size. 
Plasma exchange is used to remove the abnormal vWF and 
replace normal vYVF. In addition, supportive care includes trans- 
fusions for anemia, and hemodialysis for renal failure. The admin- 
istration of platelets for thrombocytopenia can exacerbate these 
syndromes. TTP and HUS can be difficult o identify early before 
multi-system and systemic involvement. The BMT nurses role is 
to understand these complications and ensure appropriate moni 
toting and early intervention to include assessment for: signs of 
anemia and thrombocytopenia, need for transfusions, changes in 
neurological status, weight and input/output monitoring as an 
indicator of renal function, and patient/family education. In con- 
chision, the bone marrow transplant population is at risk for TTP 
and HUS. The key to a successful outcome includes assessment 
sldlls, laboratory monitoring, and management of the multi-sys- 
tem involvement. 
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EARLY CMV REACTIVATION IS ASSOCIATED WITH GANCICLOVIR 
PROPHILAXIS ADMINISTRATED BEFORE TRANSPLANTATION 
PactJanov, E.D.; Balashov, D.N.; Skorobogwtova, E.V.; Dyshlevaia, 
Z.3/I.; S,bipitsina, LP.; Skvo~-tsova, Y. Id; ResJfick, LB.; NIaschan, A.A.; 
RTmfim~tsev, A.G. Researct: hzsftute of Pedarric Hematology, Moscow, 
Moscow, Rassirm Fedevatio**. 
We performed an analysis of incidence of CMV reactivation and 
morbidity in 71 children undergoing allogeneic HSCT during 8 
years (1994 2002). Thirty eight patients uffered from hematologi- 
cal malignancies (incl. AML, ALL, CML, MDS, lyanphoma) nd 33 
from non-malignant diseases (incl. SAA, FA, hemophagocytic syn- 
dromes, SCID, ALPS with secondary AML). Patients and methods. 
28 consecutive allo-patients in i994 - 1998 received the preventive 
ganciclovir, from day - 8 to day - 2, in order to obtain the prophylax- 
is of CMV reactivation i  post-transplant. Since 1999, 43 allo- 
patients did not received preventive ganciclovir before transplant. 
Both cohorts of patients were comparable. Results. Overall incidence 
of CMV infection, confirmed by PCR detection of virus, was 19/7 I 
transplant recipients (26, 8 %). We observed that 13/28 (46, 4 %) 
patients of ganciclovir group had a CMV reactivation, and 3 of 13 
had a confirmed CMV disease (pnemnonia 2 and colitis 1). In con- 
trast, only 6/43 (14 %) patients without ganciclovir before transplant 
demonstrated a CMV reactivation with no evidence of CMV disease. 
Conclusion. Our data suggests that prevention of CNIV reactivation 
and morbidity with ganciclovir administrated before transplant does 
not reduce the incidence of CMV infection, and furthermore the 
incidence of CMV vircmJa is parado~cally higher in patients receiv- 
ing ganciclovir prophylaxis. It may be related with retardation of 
early anti-CMV T-ceil response resulted from suppression ofhypo- 
thetically existing latent infection. We conclude that preventive gan- 
ciclovir before HSCT is not expedient. On the other hand, PCR 
monitoring of CMV infection and pre-emptive treatment ofviremia 
show their efficacy and seem to be necessary inHSCT setting. 
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DEVELOPMENT AND UTILIZATION OF A UNIFIED STRATEGIC BUSI- 
NESS PLAN FOR MARKETING BLOOD AND MARROW TRANSPLANT 
OUTPATIENT CLINIC SERVICES THE GOAL IS TO INCREASE AWARE- 
NESS OF OUTPATIENT TRANSPLANTS AND INCREASE REFERRALS 
Mebane, J.J.; Agm~a, E.D.; Be~D,THa~7 , R.B.; Fay, .7. FP:; Pmeiro, L.; 
Ua~zce, E.A.; ~q~ilso~z, A/I.C. Baylor Sammolls CmTcer Center m~d Texas 
011colo©,, P.A., Dallas, TA2 
Blood and Marrow Transplant Services, PLLC is a subsidiary of 
Texas Oncology, P.A. The outpatient clinic recently doubled in 
size to 14, 000 square feet in capacity with 6 private rooms, 16 
infusion chairs and I5 exam rooms. Charged with the goal of 
increasing awareness of outpatient transplants and referrals, clinic 
administration developed a strategic plan through surveying 
physicians, patients and clinic personnel. After compiling all the 
data received in the surveys, we developed a strategic plan through 
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